Our Blog | Biosimilars & Generics | AAM

Jul 30, 2019 | Ashlie Van Meter

A Generic Summer Savings Tour: How Did Your State Do?

Jul 29, 2019 | Maddy Murphy

Prescription Drug Safety on Campus

Jul 11, 2019 | Jonathan Kimball

The House Has Spoken – It’s Time to Fix USMCA’s Pharmaceutical Provisions

Jun 26, 2019 | Jennifer Soup

GRx+Biosims 2019: Register Now and Be Part of the Solution

Jun 25, 2019 | Erik Komendant

Section 205 is Still Flawed and Erodes the Only Incentive to Challenge Brand-Name Drug Patents. Here’s Why.

Jun 19, 2019 | Chip Davis

Congress: Don’t Punish American Patients

May 29, 2019 | Erica Klinger

Five Lessons from a National Collaboration to Promote Prescription Drug Safety

May 28, 2019 | Jewel Smith

Join AAM Today!

May 23, 2019 | Erica Klinger

WiHP Event Features Congressional Speaker

AAM Capitol Hill May 10 Briefing on NAFTA 2.0 with Representative Earl Blumenauer

May 13, 2019 | Erica Klinger

Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments

May 9, 2019 | AAM

2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report

Apr 25, 2019 | Allen Goldberg

National Drug Take Back Day Is Saturday: Here’s What You Need to Know